In GBM with low BER-SP activity (low XRCC1 levels), MPG correlates with poor outcomes, with low MPG correlated to median survival of 15.2 months and high-level MPG to only 7.9 months, p = 0.02, Supplementary Figure 5B. The gene discussed is XRCC1; the disease is glioblastoma.